코디세핀의 항염증 효과: 리뷰.

한국어 요약

2020년 발표된 「Anti-inflammatory effects of cordycepin: A review.」은(는) Cordyceps militaris (동충하초) 및 코디세핀 관련 서술적 리뷰입니다. 아래는 원문 초록을 바탕으로 한 중립적 요약이며, 제품 효능·효과를 의미하지 않습니다.

초록 요지

Cordycepin is the major bioactive component extracted from Cordyceps militaris. In recent years, cordycepin has received increasing attention owing to its multiple pharmacological activities. This study reviews recent researches on the anti-inflammatory effects and the related activities of cordycepin. The results from our review indicate that cordycepin exerts protective effects against inflammatory injury for many diseases including acute lung injury (ALI), asthma, rheumatoid arthritis, Parkinson's disease (PD), hepatitis, atherosclerosis, and atopic dermatitis. Cordycepin regulates the NF-κB, RIP2/Caspase-1, Akt/GSK-3β/p70S6K, TGF-β/Smads, and Nrf2/HO-1 signaling pathways among others. Several studies focusing on cordycepin derivatives were reviewed and found to down metabolic velocity of cordycepin and increase its bioavailability. Moreover, cordycepin enhanced immunity, inhibited the proliferation of viral RNA, and suppressed cytokine storms, thereby suggesting its potential to treat COVID-19 and other viral infections. From the collected and reviewed information, this article provides the theoretical basis for the clinical applications of cordycepin and discusses the path for future studies focusing on expanding the medicinal use of cordycepin. Taken together, cordycepin and its analogs show great potential as the next new class of anti-inflammatory agents.

전문가 메모

• 연구 수준: 리뷰·고찰 · 서술적 리뷰
• 대상: Cordyceps militaris (동충하초) / cordycepin
• 제품 연관성: direct
• 해석 주의: 원문에 질병·치료 관련 서술이 포함되어 있습니다. 본 요약은 성분·균류 연구 맥락만 중립적으로 정리했습니다.
• 인사이트: 여러 연구를 종합한 고찰이므로, 개별 실험의 질·편향을 원문 표/부록에서 확인하는 것이 좋습니다.

출처 · 원문

• 제목: Anti-inflammatory effects of cordycepin: A review.
• 저자: Lu Tan 외 9명
• 연도: 2020
• 저널: Phytotherapy research : PTR
• DOI: 10.1002/ptr.6890
• PMID: 33090621
• 링크: https://pubmed.ncbi.nlm.nih.gov/33090621/

원문 초록 (English)

Summary — Cordycepin is the major bioactive component extracted from Cordyceps militaris. In recent years, cordycepin has received increasing attention owing to its multiple pharmacological activities. This study reviews recent researches on the anti-inflammatory effects and the related activities of cordycepin. The results from our review indicate that cordycepin exerts protective effects against inflammatory injury for many diseases including acute lung injury (ALI), asthma, rheumatoid arthritis, Parkinson's disease (PD), hepatitis, atherosclerosis, and atopic dermatitis. Cordycepin regulates the NF-κB, RIP2/Caspase-1, Akt/GSK-3β/p70S6K, TGF-β/Smads, and Nrf2/HO-1 signaling pathways among others. Several studies focusing on cordycepin derivatives were reviewed and found to down metabolic velocity of cordycepin and increase its bioavailability. Moreover, cordycepin enhanced immunity, inhibited the proliferation of viral RNA, and suppressed cytokine storms, thereby suggesting its potential to treat COVID-19 and other viral infections. From the collected and reviewed information, this article provides the theoretical basis for the clinical applications of cordycepin and discusses the path for future studies focusing on expanding the medicinal use of cordycepin. Taken together, cordycepin and its analogs show great potential as the next new class of anti-inflammatory agents.

---

본 페이지는 학술 문헌을 연구·교육 목적으로 요약·정리한 자료입니다. 질병의 예방·치료·진단과 무관하며, 제왕충초 담금주의 효능·효과를 주장하지 않습니다. ‘효능 관련 논문’은 연구자들이 다루는 생리활성·기능성 주제를 뜻하며, 제품 광고 문구가 아닙니다. 원문과 상이한 해석이 있을 수 있으며, 인용 시 반드시 원문을 확인하세요.